Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pro-Change Behavior Systems is a research-driven digital health company that develops evidence-based behavior change interventions. The company's foundation is the Transtheoretical Model (TTM) of Behavior Change, developed by founder Dr. James O. Prochaska, which provides a framework for understanding how individuals progress through stages of intentional change. Their suite of products includes computer-tailored interventions for smoking cessation, weight management, stress reduction, and medication adherence. These programs are designed to assess an individual's readiness to change and provide personalized feedback to move them through the stages of change effectively. Pro-Change serves a diverse client base, including health plans, large employers, and healthcare providers, focusing on improving population health outcomes through scalable, scientifically validated technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pro-Change Behavior Systems.